About
Vaccines
Areas of Focus
Categories
VaccineSeattle/Pacific Northwest
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
1,366
By Phase
PHASE1: 2PHASE2: 2PHASE1/PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 3RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07205926Lead Sponsor
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
PHASE1Recruiting
60 participants
Started: Oct 9, 2025 · Completed: Aug 21, 2026
NCT06790290Lead Sponsor
Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants
PHASE2Active, not recruiting
421 participants
Started: Jan 27, 2025 · Completed: Dec 31, 2026
NCT06611371Lead Sponsor
Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.
PHASE1/PHASE2Active, not recruiting
600 participants
Started: Nov 12, 2024 · Completed: Feb 28, 2026
NCT06077656Lead Sponsor
Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
PHASE2Active, not recruiting
220 participants
Started: Oct 25, 2023 · Completed: May 24, 2024
NCT05540028Lead Sponsor
Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
PHASE1Completed
65 participants
Started: Sep 28, 2022 · Completed: Jul 31, 2023
Funding History (1)
D
Nov 16, 2021
Locations (1)
Headquarters
Redmond, WA, United States
Map
Loading map...